Jove
Visualize
Contact Us

Related Concept Videos

iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Label-free assessment of a microfluidic vessel-on-chip model with visible-light optical tomography reveals structural changes in vascular networks.

Lab on a chip·2026
Same author

STARTER: a stand-alone reconfigurable and translational organ-on-chip platform based on modularity and open design principles.

Lab on a chip·2026
Same author

<i>Mapping cardiac drug transport: In vitro</i> assessment of cardiac P-glycoprotein function with [<sup>18</sup>F]MC225 by using µ-engineered heart tissues.

European heart journal open·2025
Same author

Cytokine-induced memory-like responses in endothelial cells link chronic inflammation to vascular disease risk.

Molecular omics·2025
Same author

Blood-perfused Vessels-on-Chips stimulated with patient plasma recapitulate endothelial activation and microthrombosis in COVID-19.

Lab on a chip·2025
Same author

Retina-on-chip: engineering functional <i>in vitro</i> models of the human retina using organ-on-chip technology.

Lab on a chip·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 25, 2026

The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
10:05

The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture

Published on: April 28, 2015

29.1K

Facilitating implementation of organs-on-chips by open platform technology.

Anke R Vollertsen, Aisen Vivas, Berend van Meer

  • 1BIOS Lab on a Chip Group, MESA+ Institute for Nanotechnology, Max Planck Institute for Complex Fluid Dynamics, University of Twente, Enschede, the Netherlands.

Biomicrofluidics
|October 18, 2021
PubMed
Summary

Standardizing organ-on-chip (OoC) and multi-organs-on-chip (MOoC) systems is crucial for drug discovery and personalized medicine. An open platform with standardized interfaces will improve usability and interoperability, accelerating adoption in research and industry.

More Related Videos

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

26.9K
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

12.9K

Related Experiment Videos

Last Updated: Jun 25, 2026

The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
10:05

The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture

Published on: April 28, 2015

29.1K
Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

26.9K
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

12.9K

Area of Science:

  • Biotechnology
  • Drug Discovery
  • Personalized Medicine

Background:

  • Organ-on-chip (OoC) and multi-organs-on-chip (MOoC) systems show promise for drug discovery, disease modeling, and personalized medicine.
  • Current academic OoC devices often lack user-friendliness and scalability, while commercial options lack complexity and interoperability.
  • Researchers face limitations when combining chips from different suppliers for MOoC systems due to incompatibility.

Purpose of the Study:

  • To define the concept of an open platform for OoCs from a technical standpoint.
  • To highlight the necessity of standardization for broader acceptance and application of OoC and MOoC technologies.
  • To emphasize the importance of multi-stakeholder involvement in developing and implementing open OoC platforms.

Main Methods:

  • This perspective article defines an open platform concept for OoCs.
  • It discusses the technical requirements for standardized interfacing and user-friendly operation.
  • It analyzes the need for collaboration between academia and industry.

Main Results:

  • Standardization of OoC and MOoC systems is essential for widespread adoption.
  • An open platform with standardized interfaces can address current limitations in usability and interoperability.
  • Involving diverse stakeholders is key to successful implementation and acceptance.

Conclusions:

  • Implementing standards in OoC and MOoC design and operation will accelerate their use in research and industry.
  • An open platform approach, balancing standardization with proprietary development, is proposed.
  • Collaborative development involving industry and academia is critical for the future of OoC technology.